Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 1874, 2007; 10.1373/clinchem.2007.092759
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Database
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stolper, S. I.
Right arrow Articles by Kricka, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stolper, S. I.
Right arrow Articles by Kricka, L. J.
Related Collections
Right arrow Other Areas of Clinical Chemistry
Right arrow Point-of-Care Testing
(Clinical Chemistry. 2007;53:1874.)
© 2007 American Association for Clinical Chemistry, Inc.

Letters to the Editor

Nanotechnology and Immunoassay

Samuel I. Stolpera, Sonny S. Mark, Jason Y. Park and Larry J. Kricka

Center for Biomedical, Micro and Nanotechnology, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania, Medical Center, Philadelphia, PA

aAddress correspondence to this author at: 7.103 Founders Pavilion, Hospital of the University of Pennsylvania, 3400 Spruce St., Philadelphia, PA 19104. Fax 215-662-7529; e-mail stolper@mail.med.upenn.edu.

The first 20% of the full text of this article appears below.


To the Editor:

The roots of nanotechnology can be traced back to colloid science in the mid-19th century. Francesco Selmi, often credited with the first true research in the field, studied the behavior of various metallic and acidic emulsions in the 1840s (1). Shortly thereafter, Michael Faraday and Thomas Graham, two scientific pioneers known primarily for their work with electricity and diffusion of gases, respectively, contributed further to the analysis of nanoparticulate suspensions, i.e., colloids. Faraday’s studies in electrochemistry naturally led him to the first experiments with colloidal gold(2), and Graham coined the term . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
 J. Clin. Pathol.Home page
A A A Ismail
Interference from endogenous antibodies in automated immunoassays: what laboratorians need to know
J. Clin. Pathol., August 1, 2009; 62(8): 673 - 678.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.